Logo

American Heart Association

  12
  0


Final ID: MDP1668

Comparing predictors of atrial fibrillation recurrence following de novo versus repeat catheter ablation

Abstract Body (Do not enter title and authors here): Background: Approximately 1 of 5 catheter ablations for atrial fibrillation (AF) are repeat procedures. Despite this, little is known about risk factors for recurrence in patients undergoing repeat ablation compared with those undergoing de novo ablation.

Objective: To compare predictors of AF recurrence following de novo and repeat catheter ablation.

Methods: To compare AF recurrence between those with and without prior ablation, we conducted a retrospective cohort study of patients undergoing catheter ablation for treatment of symptomatic and drug-refractory AF. In this analysis, early recurrence was defined as 30 seconds of AF, atrial flutter, or atrial tachycardia within a 3-month blanking period, while late recurrence was defined as recurrent arrhythmia at >3 months. Multivariable Cox proportional hazard regression analysis was used to identify independent factors associated with recurrence.

Results: Among 659 patients, 487 (mean age 63.3 +/- 10.1 years, 33% female, CHA2DS2-VASc 2.8 +/- 1.8, 62% paroxysmal) underwent de novo ablation and 172 (mean age 65.1 +/- 10.0 years, 34% female, CHA2DS2-VASc 3.1 +/- 1.9, 60% paroxysmal) underwent repeat ablation with average follow up of 24.4+/-18.4 months. Multivariable modeling revealed that left atrial volume index (LAVi) [HR 1.015, p<0.0001], body mass index (BMI) [HR 1.025, p=0.043], and early recurrence [HR 2.496, p<0.0001] were predictive of late recurrence in the de novo ablation cohort, compared to LAVi [HR 1.014, p=0.006] and early recurrence [HR 2.053, p=0.001] in the repeat ablation cohort. Age, sex, AF type (paroxysmal vs non-paroxysmal), obstructive sleep apnea, heart failure, CHA2DS2-VASc scores, and energy source (cryoballoon vs radiofrequency) were not predictive of recurrence in either cohort (p>0.05). There was a trend towards higher probability of recurrence following repeat ablation (log-rank p=0.052).

Conclusion: Predictors of late AF recurrence following de novo and repeat catheter ablation are similar at >2 years follow-up. The left atrial volume index and early recurrence are the strongest predictors of late recurrence.
  • Brahier, Mark  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Schwennesen, Hannah  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Vista, Andrew  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Friedman, Daniel  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Piccini, Jonathan  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Author Disclosures:
    Mark Brahier: DO NOT have relevant financial relationships | Hannah Schwennesen: No Answer | Andrew Vista: DO NOT have relevant financial relationships | Daniel Friedman: DO have relevant financial relationships ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Research Funding (PI or named investigator):Phillips:Active (exists now) ; Consultant:MicroPort CRM:Past (completed) ; Consultant:Alleviant:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Medtronic :Active (exists now) ; Consultant:Abbott:Active (exists now) ; Research Funding (PI or named investigator):Merit Medical:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Jonathan Piccini: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Phillips:Active (exists now) ; Research Funding (PI or named investigator):iRhythm:Active (exists now) ; Other (please indicate in the box next to the company name):Kardium:Active (exists now) ; Consultant:Milestone:Active (exists now) ; Consultant:ABVF:Active (exists now) ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

One and Done or Three-Peat? Understanding, Predicting and Preventing Recurrence in AFib Ablation

Monday, 11/18/2024 , 12:50PM - 02:05PM

Moderated Digital Poster Session

More abstracts on this topic:

A Large Animal Model of Persistent Atrial Fibrillation

Mostafizi Pouria, Goldman Steven, Moukabary Talal, Lefkowitz Eli, Ref Jacob, Daugherty Sherry, Grijalva Adrian, Cook Kyle Eric, Chinyere Ike, Lancaster Jordan, Koevary Jen

All Things in Moderation: Right Ventricular Moderator Band Induced Ventricular Fibrillation In A Young Male

Kamran Wali, Pusukur Bharani, Sutton Peter, Rao Yash, Deboer Rebecca, Al-mohamad Talal, Cossu Sergio, Patel Kunal

More abstracts from these authors:
Coffee and Calesthenics: AF Risk Factor Modification - Where do we stand?

Sanders Prashanthan, Marcus Gregory, Piccini Jonathan

The Earlybird Gets the Worm: AF in Heart Failure - Is Earlier is Better?

Gopinathannair Rakesh, Piccini Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available